English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52886819    線上人數 :  807
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"lin y t"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 36-45 / 1310 (共131頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-09-06T02:42:20Z The association between glomerular hyperfiltration and left ventricular structure and function in patients with primary aldosteronism Liao M.-T.; Wu X.-M.; Chang C.-C.; Liao C.-W.; Chen Y.-H.; Lu C.-C.; Lin Y.-T.; Chang Y.-Y.; Hung C.-S.; Lin L.-C.; Lai C.-L.; LIAN-YU LIN; Wu V.-C.; Ho Y.-L.; Wu K.-D.; Lin Y.-H.; TAIPAI Study Group
臺大學術典藏 2022-09-06T02:42:14Z Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: Prospective study of 102 patients Liao C.-W.; LIAN-YU LIN; Hung C.-S.; Lin Y.-T.; Chang Y.-Y.; Wang S.-M.; Wu V.-C.; Wu K.-D.; Ho Y.-L.; Satoh F.; Lin Y.-H.
臺大學術典藏 2022-07-19T01:50:36Z Erratum: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress (Oncotarget (2019) 10 (3577–3578) DOI: 10.18632/oncotarget.1628) Lin Y.-C.; Wu M.-H.; TZU-TANG WEI; Huang W.-C.; Huang L.-Y.; Lin Y.-T.; Chen C.-C.
臺大學術典藏 2022-06-27T07:01:45Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; CHONG-JEN YU; Wu S.-G.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:00:17Z Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review Lin Y.-T.; CHONG-JEN YU; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:00:15Z Transthoracic Ultrasound Elastography in Pulmonary Lesions and Diseases Lim C.-K.; Chung C.-L.; Lin Y.-T.; Chang C.-H.; Lai Y.-C.; Wang H.-C.; CHONG-JEN YU
臺大學術典藏 2022-06-27T06:59:53Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏 2022-06-27T06:59:44Z Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer Lin Y.-T.; Tsai T.-H.; Wu S.-G.; Liu Y.-N.; CHONG-JEN YU; Shih J.-Y.
臺大學術典藏 2022-06-27T02:49:09Z Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors in NSCLC: Two Heads Are Better Than One Lin Y.-T.; JIN-YUAN SHIH
臺大學術典藏 2022-06-10T06:10:58Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; ZHONG-ZHE LIN; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.

顯示項目 36-45 / 1310 (共131頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目